The vaccine by Pfizer-BioNTech is the first vaccine that has been lincensed for COVID-19. The mRNA vaccine has shown to prevent 95 percent of COVID-19 during the clinical trials and can…
Zydus Cadila’s DNA based vaccine ZyCoV-D becomes the first vaccine to receive emergency use authorization for children above 12 years of age. The three-dose vaccine has an efficacy rate of…
Moderna has developed several drugs with its cost and time effective mRNA technology that are currently undergoing trials for HIV, cancer, heart diseases and genetic disorders that could potentially lead…
Health ministry on Monday informed that as many as 32.8 crore doses of Covid-19 vaccines have been administered since the start of the vaccination drive that began from January 16….
European countries including, Austria, Germany, Slovenia, Greece, Estonia, Iceland, Ireland and Spain, and Switzerland have approved the Covishield COVID-19 vaccine for ‘Green Pass’. This comes after India has asked the…
Highlights: Fifth vaccine to be authorized in India. Now effective with two doses. Company to manufacture 120M doses a year. If approved, it could be World’s first plasmid DNA shot….
The Maryland based company, Novavax’s covid-19 vaccine candiate, named Covavax in India is all set to be launched in August-September this year in association with the Pune based Serum Institute…
A 68 year old man has died after being fully vaccinated with the covishield vaccine in the month of March due to anaphylaxis, which is considered as a severe allergic…
Several speculations are doing the rounds regarding the possibility of a third wave and if children are at a risk of getting infected in the subsequent wave. There is a…
An Adelaide based company, Vaxine Pty Ltd has successfully developed a COVID vaccine, COVAX-19 that holds the ability to completely prevent the covid-19 virus transmission in non-immune individuals. No other…
Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila